web analytics
10.1 C
Friday, October 7, 2022

Todays Stock Spotlight is United Cannabis Corp. (OTCBB:CNAB)

United Cannabis Corp. (OTCBB:CNAB) is an interesting story developing in small caps that currently sits a hair over all-time lows and proven support levels.

CNAB got everyone’s attention back in 2014 when it ran from pennies to well over $10 a share during the pot stock boom that swept up the bb’s.

United Cannabis Corp. (OTCBB:CNAB) was founded to provide leadership for the medical cannabis industry by offering patient-driven solutions intent on improving biomedical and pharmaceutical pursuits through the use of cannabis-based research, products and services.

United Cannabis Corp came into being in May 2014 after the name change from MySkin Inc to reflect the Company’s entry into the pot industry. The shell was originally formed as a California Corp on November 15, 2007. The Company changed their state of incorporation to Colorado when they changed their name to United Cannabis Corp.

The stars aligned for CNAB when the U.S. Justice Department recently said that Indian tribes can grow and sell marijuana on their lands as long as they follow the same federal conditions laid out for states that have legalized pot. This opened up the door for Indian Reservations to mount large scale grow operations and United Cannabis Corp along with FoxBarry Farms has emerged as the de facto consultant and business partner in this new emerging multi-billion dollar industry.

CNAB A.C.T. Now Program and patent-pending Prana Bio Nutrient Medicinals provide a comprehensive solution, designed to enable physicians and patients to design, implement and monitor effective therapy protocols.

CNAB focus is to develop and license proprietary cannabinoid products for a variety of therapeutics applications as well as license their proprietary software to physicians seeking cannabinoid-­‐based products.

To Find out the inside Scoop on CNAB Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

In August CNAB said it has opened its first California-based Advanced Cannabinoid Therapy or “A.C.T.” Now Clinic in the Harborside Health Center (“Harborside”) at 1840 Embarcadero, in Oakland.

United Cannabis has granted Harborside Health Center, Oakland a license to sell its patent-pending Prana Bio Nutrient Medicinals line in its Oakland facility. The initial license covers a four-month term, with the expectation of establishing a long-term relationship following an initial trial period.

The A.C.T. Now Program is designed to help patients achieve the correct combination of Prana Bio Nutrient Medicinal products, based on their condition and to provide additional services including nursing support, nutritional guidelines and patient education. By achieving the correct cannabinoid ratios with accurate dosing, many patients have found positive results in treating chronic pain, opiate dependency, inflammation, PTSD, neuropathy, multiple sclerosis, fibromyalgia, Crohn’s, IBS, seizures, epilepsy, paralysis, autoimmune disorders, autism, tumors, HIV/AIDS, as well as many types of cancer.

On September 3 CNAB announced it has signed a Consulting Agreement with cannabis product entrepreneur Marcus “Bubbleman” Richardson, to serve as exclusive managing agent for Bubbleman-branded products in certain licensed markets in the United States.

According to the press release CNAB will serve as exclusive brand ambassador for Bubbleman-branded products Bubbleman will provide training and oversight to ensure proper production of branded products and CNAB will provide the administrative, sales and marketing support associated with the sale of Bubbleman products, initially in Harborside Health Center, in Oakland, California

Bubbleman processes raw cannabis plants for industrial growers using his proprietary processing technologies. His methodologies utilize water, ice and dry-sifting to process plants, rather than chemicals, to ensure a pure resin end-product. Marcus “Bubbleman” Richardson has been credited for coining the phrase “bubble hash” and Mr. Richardson is also the Chief Technology Officer of Cannabis Research and Development Limited, the Company’s Jamaican-based business partner.

We have a Monster Pick Coming. Subscribe Right Now!

Currently trading at a $19 million market valuation CNAB has minimal assets, small but growing revenues and growing short term debt. But this is an exciting story in small caps: CNAB has some exciting projects in the works and a growing shareholder base who believes this one goes higher We will be updating on CNAB when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with CNAB.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in CNAB either long or short and we have not been compensated for this article

More articles



Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.